IRIS Accounts Production v25.2.0.378 10178950 director 1.1.24 31.12.24 31.12.24 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh101789502023-12-31101789502024-12-31101789502024-01-012024-12-31101789502022-12-31101789502023-01-012023-12-31101789502023-12-3110178950ns15:EnglandWales2024-01-012024-12-3110178950ns14:PoundSterling2024-01-012024-12-3110178950ns10:Director12024-01-012024-12-3110178950ns10:PrivateLimitedCompanyLtd2024-01-012024-12-3110178950ns10:SmallEntities2024-01-012024-12-3110178950ns10:AuditExempt-NoAccountantsReport2024-01-012024-12-3110178950ns10:SmallCompaniesRegimeForDirectorsReport2024-01-012024-12-3110178950ns10:SmallCompaniesRegimeForAccounts2024-01-012024-12-3110178950ns10:FullAccounts2024-01-012024-12-3110178950ns10:OrdinaryShareClass12024-01-012024-12-3110178950ns10:RegisteredOffice2024-01-012024-12-3110178950ns5:CurrentFinancialInstruments2024-12-3110178950ns5:CurrentFinancialInstruments2023-12-3110178950ns5:Non-currentFinancialInstruments2024-12-3110178950ns5:Non-currentFinancialInstruments2023-12-3110178950ns5:ShareCapital2024-12-3110178950ns5:ShareCapital2023-12-3110178950ns5:RetainedEarningsAccumulatedLosses2024-12-3110178950ns5:RetainedEarningsAccumulatedLosses2023-12-3110178950ns5:ShareCapital2022-12-3110178950ns5:RetainedEarningsAccumulatedLosses2022-12-3110178950ns5:RetainedEarningsAccumulatedLosses2023-01-012023-12-3110178950ns5:RetainedEarningsAccumulatedLosses2024-01-012024-12-3110178950ns5:FurnitureFittings2024-01-012024-12-3110178950ns5:MotorVehicles2024-01-012024-12-3110178950ns5:ComputerEquipment2024-01-012024-12-3110178950ns5:FurnitureFittings2023-12-3110178950ns5:MotorVehicles2023-12-3110178950ns5:ComputerEquipment2023-12-3110178950ns5:FurnitureFittings2024-12-3110178950ns5:MotorVehicles2024-12-3110178950ns5:ComputerEquipment2024-12-3110178950ns5:FurnitureFittings2023-12-3110178950ns5:MotorVehicles2023-12-3110178950ns5:ComputerEquipment2023-12-3110178950ns5:LeasedAssetsHeldAsLesseens5:MotorVehicles2024-01-012024-12-3110178950ns5:LeasedAssetsHeldAsLesseens5:MotorVehicles2024-12-3110178950ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3110178950ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-3110178950ns5:WithinOneYearns5:CurrentFinancialInstrumentsns5:HirePurchaseContracts2024-12-3110178950ns5:WithinOneYearns5:CurrentFinancialInstrumentsns5:HirePurchaseContracts2023-12-3110178950ns5:HirePurchaseContractsns5:BetweenOneFiveYears2024-12-3110178950ns5:HirePurchaseContractsns5:BetweenOneFiveYears2023-12-3110178950ns5:HirePurchaseContracts2024-12-3110178950ns5:HirePurchaseContracts2023-12-3110178950ns5:WithinOneYear2024-12-3110178950ns5:WithinOneYear2023-12-3110178950ns10:OrdinaryShareClass12024-12-3110178950ns10:Director112023-12-3110178950ns10:Director112022-12-3110178950ns10:Director112024-01-012024-12-3110178950ns10:Director112023-01-012023-12-3110178950ns10:Director112024-12-3110178950ns10:Director112023-12-31
REGISTERED NUMBER: 10178950 (England and Wales)












UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024

FOR

SHS PARTNERS SURGICAL LIMITED

SHS PARTNERS SURGICAL LIMITED (REGISTERED NUMBER: 10178950)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024










Page

Company Information 1

Balance Sheet 2

Statement of Changes in Equity 3

Notes to the Financial Statements 4


SHS PARTNERS SURGICAL LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2024







DIRECTOR: M J Reidy





REGISTERED OFFICE: The Gatehouse
Kay Street
Summerseat
Bury
BL9 5PE





REGISTERED NUMBER: 10178950 (England and Wales)





ACCOUNTANTS: Donachie Chartered Accountants
2nd Floor
Templeton House
62 Templeton Street
Glasgow
G40 1DA

SHS PARTNERS SURGICAL LIMITED (REGISTERED NUMBER: 10178950)

BALANCE SHEET
31 DECEMBER 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 76,598 1,583

CURRENT ASSETS
Debtors 5 524,454 896,382
Cash at bank 731,978 1,076,415
1,256,432 1,972,797
CREDITORS
Amounts falling due within one year 6 204,979 282,997
NET CURRENT ASSETS 1,051,453 1,689,800
TOTAL ASSETS LESS CURRENT LIABILITIES 1,128,051 1,691,383

CREDITORS
Amounts falling due after more than one year 7 62,112 -
NET ASSETS 1,065,939 1,691,383

CAPITAL AND RESERVES
Called up share capital 10 100 100
Retained earnings 1,065,839 1,691,283
SHAREHOLDERS' FUNDS 1,065,939 1,691,383

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 17 September 2025 and were signed by:





M J Reidy - Director


SHS PARTNERS SURGICAL LIMITED (REGISTERED NUMBER: 10178950)

STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2024

Called up
share Retained Total
capital earnings equity
£    £    £   
Balance at 1 January 2023 100 1,007,676 1,007,776

Changes in equity
Dividends - (536,400 ) (536,400 )
Total comprehensive income - 1,220,007 1,220,007
Balance at 31 December 2023 100 1,691,283 1,691,383

Changes in equity
Dividends - (322,220 ) (322,220 )
Total comprehensive loss - (303,224 ) (303,224 )
Balance at 31 December 2024 100 1,065,839 1,065,939

SHS PARTNERS SURGICAL LIMITED (REGISTERED NUMBER: 10178950)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024


1. STATUTORY INFORMATION

SHS Partners Surgical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion, when the stage of completion, costs incurred to date and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent that it will be recoverable.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Fixtures and fittings - 25% reducing balance
Motor vehicles - 25% straight line
Computer equipment - Straight line over 3 years

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

SHS PARTNERS SURGICAL LIMITED (REGISTERED NUMBER: 10178950)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024


2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Financial instruments
Financial instruments are classified and accounted for as financial assets, financial liabilities or equity instruments, according to the substance of the contractual arrangement.

Financial instruments which are assets are stated at cost less any provision for impairment. Financial liabilities are stated at principal capital amounts outstanding at the period end. Issue costs relating to financial liabilities are deducted from the outstanding balance and are amortised over the period to the due date for repayment of the financial liability.

An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. A financial liability is any contractual arrangement for an entity to deliver cash to the holder of the associated financial instrument.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 9 (2023 - 9 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
and Motor Computer
fittings vehicles equipment Totals
£    £    £    £   
COST
At 1 January 2024 5,257 - 5,698 10,955
Additions - 82,347 2,097 84,444
At 31 December 2024 5,257 82,347 7,795 95,399
DEPRECIATION
At 1 January 2024 3,674 - 5,698 9,372
Charge for year 597 8,235 597 9,429
At 31 December 2024 4,271 8,235 6,295 18,801
NET BOOK VALUE
At 31 December 2024 986 74,112 1,500 76,598
At 31 December 2023 1,583 - - 1,583

SHS PARTNERS SURGICAL LIMITED (REGISTERED NUMBER: 10178950)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024


4. TANGIBLE FIXED ASSETS - continued

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:
Motor
vehicles
£   
COST
Additions 82,347
At 31 December 2024 82,347
DEPRECIATION
Charge for year 8,235
At 31 December 2024 8,235
NET BOOK VALUE
At 31 December 2024 74,112

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 372,369 796,033
Amounts owed by group undertakings 13,800 15,801
Other debtors - 2,344
Corporation tax recoverable 95,826 -
Prepayments and accrued income 42,459 82,204
524,454 896,382

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Hire purchase contracts (see note 8) 7,563 -
Trade creditors 105,179 81,598
Amounts owed to group undertakings 821 -
Corporation tax - 96,349
Social security and other taxes 6,142 14,827
VAT 51,726 50,741
Directors' loan accounts 59 59
Accruals and deferred income 33,489 39,423
204,979 282,997

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2024 2023
£    £   
Hire purchase contracts (see note 8) 62,112 -

SHS PARTNERS SURGICAL LIMITED (REGISTERED NUMBER: 10178950)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024


8. LEASING AGREEMENTS

Minimum lease payments fall due as follows:

Hire purchase
contracts
2024 2023
£    £   
Net obligations repayable:
Within one year 7,563 -
Between one and five years 62,112 -
69,675 -

Non-cancellable
operating leases
2024 2023
£    £   
Within one year 12,000 12,686

9. SECURED DEBTS

The following secured debts are included within creditors:

2024 2023
£    £   
Hire purchase contracts 69,675 -

10. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
100 Ordinary £1 100 100

11. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 December 2024 and 31 December 2023:

2024 2023
£    £   
M J Reidy
Balance outstanding at start of year (59 ) (59 )
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (59 ) (59 )

SHS PARTNERS SURGICAL LIMITED (REGISTERED NUMBER: 10178950)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024


12. RELATED PARTY DISCLOSURES

During the year, the Company paid expenses on behalf of its parent Company Strategic Healthcare Services Limited totalling £2,178 (2023 - £1,980) and Strategic Healthcare Services paid expenses on behalf of SHS Partners Surgical Limited totalling £NIL (2023 - £3,579). The balance due to / from Strategic Healthcare Services Limited was £821 (2023 - (£2,001)).

During the year, the Company paid expenses on behalf of an associated Company SHS Pathology Limited totalling £NIL (2023 - £5,209). Included in other debtors at the year end, the balance due from SHS Pathology Limited was £13,800 (2023 - £13,800).

13. PARENT COMPANY

The company's ultimate parent company is Strategic Healthcare Services Limited, a company registered in England and Wales.